Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

Conditions:   Breast Cancer;   Metastatic Breast Cancer;   Hormone Receptor-positive Breast Cancer;   HER2-negative Breast Cancer Interventions:   Drug: Fulvestrant;   Drug: Anastrozole;   Drug: Abemaciclib Sponsor:   University of California, Irvine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials